Order Article Reprints

Alfredo C-A, Noemí C-R, Samuel R-L, Daniel O-C, Rodrigo R-B, Paul M-T, Mónica E-T, José C-B, Eleazar L-P, Alfonso A-R, et al. Effect of Norelgestromin and Ethinylestradiol in Transdermal Patches on the Clinical Outcomes and Biochemical Parameters of COVID-19 Patients: A Clinical Trial Pilot Study. Pharmaceuticals. 2022; 15(6):757. https://doi.org/10.3390/ph15060757

Alfredo, Cortés-Algara, Cárdenas-Rodríguez Noemí, Reyes-Long Samuel, Ortega-Cuellar Daniel, Ruz-Barros Rodrigo, Mondragón-Terán Paul, Escamilla-Tilch Mónica, Correa-Basurto José, Lara-Padilla Eleazar, Alfaro-Rodríguez Alfonso, and et al. 2022. "Effect of Norelgestromin and Ethinylestradiol in Transdermal Patches on the Clinical Outcomes and Biochemical Parameters of COVID-19 Patients: A Clinical Trial Pilot Study" Pharmaceuticals 15, no. 6: 757. https://doi.org/10.3390/ph15060757

Alfredo, C.-A., Noemí, C.-R., Samuel, R.-L., Daniel, O.-C., Rodrigo, R.-B., Paul, M.-T., Mónica, E.-T., José, C.-B., Eleazar, L.-P., Alfonso, A.-R., Luis, C.-A. J., & Cindy, B. (2022). Effect of Norelgestromin and Ethinylestradiol in Transdermal Patches on the Clinical Outcomes and Biochemical Parameters of COVID-19 Patients: A Clinical Trial Pilot Study. Pharmaceuticals, 15(6), 757. https://doi.org/10.3390/ph15060757